Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Insulet revolutionizes diabetes management with its innovative Omnipod System, a tubeless insulin pump offering a discreet and simple solution for people with insulin-dependent diabetes. This medical technology company develops and distributes cutting-edge technologies to enhance quality of life.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Insulet is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Insulet last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 1.66 USD.
Across its last 3 earnings reports, Insulet stock moved by ±5.8% on average the following day. The largest reaction was -9.7% on 05/06/2026; 2 of 3 reactions were positive.
Insulet has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.